Physician profile
Malcolm A Smith
NPI 1174525174
$12,646.46
in general payments reported to CMS, 2019-2025
44 companies · $2,563 in 2025
The $2,563 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $295 · 2021: $767 · 2022: $1,440 · 2023: $4,657 · 2024: $2,409 · 2025: $2,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,518 · Travel and Lodging: $1,796 · Education: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,517.52 |
| Travel and Lodging | $1,795.56 |
| Education | $315.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,219.65 | 2021-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,492.13 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Zoll Respicardia, INC. | $1,430.87 | 2023-2025 | Remede System |
| Actelion Pharmaceuticals US, INC. | $928.10 | 2019-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $873.61 | 2021-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $803.63 | 2019-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals Lp | $662.27 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $647.41 | 2019-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $489.76 | 2022-2025 | Wakix |
| Genzyme Corporation | $303.06 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $281.73 | 2019-2025 | |
| Amgen INC. | $220.69 | 2019-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $211.11 | 2021-2025 | Glassia |
| Mallinckrodt Hospital Products INC. | $195.55 | 2022-2025 | Acthar |
| Inogen, INC. | $184.17 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.